Download Library

Title Documents

View Form 8937 - January 7, 2015

View Form 8937 - July 15, 2014

Theravance, Inc. Addendum to Conflict of Interest Policy
with Regard to Theravance Biopharma, Inc. Matters

Audit Committee Charter

Comprehensive Compliance Program and Declaration

Science and Technology Advisory Committee Charter.

Bylaws

Compensation Committee Charter

Nominating & Corporate Governance Committee Charter

Copyright Nasdaq. Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.